Skip to main content
Equibles
AGL logo

AGL · agilon health, inc. · Earnings Call Transcripts & Audio

Track AGL — free

Use AGL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AGL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$83.12 +3.53 (+4.44%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.37B
Shares
16.79M
Volume · Oct 1 106.07K Avg daily vol (3M) 294.84K

agilon health, inc. Earnings Call Transcripts

Quarterly earnings calls for agilon health, inc. (AGL), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲51.5% $694.86M −$30.67M '22 Q3 22-11-03 ▲145.2% $369.78M −$56.47M '22 Q4 23-03-01 ▲61.3% $1.05B $16.02M '23 Q1 23-05-09 ▲59.5% $1.07B −$16.75M '23 Q2 23-08-03 ▲63.6% $1.14B −$31.44M '23 Q3 23-11-02 ▲185.6% $1.06B −$230.43M '23 Q4 24-02-27 ▲52.2% $1.60B −$6.06M '24 Q1 24-05-07 ▲38.7% $1.48B −$30.68M '24 Q2 24-08-06 ▲27.6% $1.45B −$117.61M '24 Q3 24-11-07 ▲44.2% $1.52B −$105.79M '24 Q4 25-02-25 ▼4.5% $1.53B $12.11M '25 Q1 25-05-06 ▼5.9% $1.39B −$104.37M '25 Q2 25-08-04 ▼1.1% $1.44B −$110.21M '25 Q3 25-11-04 ▲3.1% $1.57B −$188.88M '25 Q4 26-02-25 ▼7.3% $1.42B $48.92M '26 Q1 26-05-06 LATEST ▲7.2% $1.49B $17.96M '26 Q2 26-08-05
Conference
Investor event
2026-09-14
agilon health, inc. (AGL) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
agilon health, inc. (AGL) Q2 2026 Earnings Call Transcript
Positive tone Guidance raise and quarterly outperformance Burden of illness / quality program value Clinical programs (CHF, dementia, lung health)
Revenue
$1.49B
▲ 7.2% YoY
Diluted EPS
$1.04
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-23
agilon health, inc. (AGL) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
agilon health, inc. (AGL) Q1 2026 Earnings Call Transcript
Confident tone Risk adjustment and regulatory environment (CMS/LEAD) Data pipeline and analytics 2026 guidance raise
Revenue
$1.42B
▼ 7.3% YoY
Diluted EPS
$2.94
▲ 302.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
agilon health, inc. (AGL) Q4 2025 Earnings Call Transcript
Balanced tone Cost trend and utilization pressure Quality programs and Stars ratings 2026 financial guidance and outlook
Revenue
$1.57B*
▲ 3.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
agilon health, inc. (AGL) Q3 2025 Earnings Call Transcript
Balanced tone Clinical Programs and Burden of Illness (BOI) Enhanced Data Pipeline and Analytics Stars Ratings and Quality Performance
Revenue
$1.44B
▼ 1.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2025-09-30
agilon health, inc. (AGL) September 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-08-04
agilon health, inc. (AGL) Q2 2025 Earnings Call Transcript
Cautious tone Execution and Accountability 2026 Outlook and Strategic Initiatives Risk Adjustment / 2024 Baseline
Revenue
$1.39B
▼ 5.9% YoY
Diluted EPS
$-6.31
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
agilon health, inc. (AGL) Q1 2025 Earnings Call Transcript
Positive tone Part D and supplemental benefit exposure Q1 results and full-year guidance Medicare Advantage and CMS rate environment
Revenue
$1.53B
▼ 4.5% YoY
Diluted EPS
$0.73
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
agilon health, inc. (AGL) Q4 2024 Earnings Call Transcript
Balanced tone Part D exposure reduction Medicare Advantage cost trend and utilization cycle Path to profitability and cash flow breakeven
Revenue
$1.52B*
▲ 44.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
agilon health, inc. (AGL) Q3 2024 Earnings Call Transcript
Cautious tone Data lag, risk adjustment, and claims information challenges 2025 jumping-off point and business mix improvement Disappointing Q3 financial results and lowered guidance
Revenue
$1.45B
▲ 27.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
agilon health, inc. (AGL) Q2 2024 Earnings Call Transcript
Cautious tone Medical cost trends and utilization Membership and revenue guidance PCP engagement and high-risk patient management
Revenue
$1.48B
▲ 38.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
agilon health, inc. (AGL) Q1 2024 Earnings Call Transcript
Positive tone Guidance and quarterly performance Medicare Advantage funding environment Medical cost trend and utilization
Revenue
$1.60B
▲ 52.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
agilon health, inc. (AGL) Q4 2023 Earnings Call Transcript
Cautious tone 2023 results miss and lowered 2024 guidance Balance sheet and liquidity Higher utilization and medical cost trend
Revenue
$1.06B*
▲ 185.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
agilon health, inc. (AGL) Q3 2023 Earnings Call Transcript
Revenue
$1.14B
▲ 63.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
agilon health, inc. (AGL) Q2 2023 Earnings Call Transcript
Revenue
$1.07B
▲ 59.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
agilon health, inc. (AGL) Q1 2023 Earnings Call Transcript
Revenue
$1.05B
▲ 61.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-01
agilon health, inc. (AGL) Q4 2022 Earnings Call Transcript
Revenue
$369.78M*
▲ 145.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
agilon health, inc. (AGL) Q3 2022 Earnings Call Transcript
Revenue
$694.86M
▲ 51.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
agilon health, inc. (AGL) Q2 2022 Earnings Call Transcript
Revenue
$670.13M
▲ 34.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
agilon health, inc. (AGL) Q1 2022 Earnings Call Transcript
Revenue
$653.45M
▲ 58.2% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-04
agilon health, inc. (AGL) Q4 2021 Earnings Call Transcript
Revenue
$150.82M*
▼ 53% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-29
agilon health, inc. (AGL) Q3 2021 Earnings Call Transcript
Revenue
$458.61M
▲ 46.7% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
agilon health, inc. (AGL) Q2 2021 Earnings Call Transcript
Revenue
$498.96M
▲ 69.9% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-27
agilon health, inc. (AGL) Q1 2021 Earnings Call Transcript
Revenue
$413.10M
▲ 41.9% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1831097 CUSIP 00857U206 13F (30d) 4 filings 4 filers Visit website Investor relations